Over the past five years, Dr. Christopher Exley and his team of scientists at Keele University in England have made extraordinary progress in aluminum toxicity research, thanks to funding by CMSRI. As a result, the world of medical science is no longer asking IF aluminum is present in brain tissue, but HOW MUCH is there, WHERE is it and WHAT DAMAGE is it doing?
Below are the landmark studies that have revealed the way in which aluminum in vaccines migrates to the brain and the extremely high levels of aluminum found in the brains of individuals diagnosed with autism, Alzheimer’s disease and Multiple Sclerosis.
Pending adequate funding, the following are other studies planned by the Keele University team to unearth the answers to today's most pressing health concerns:
- A large control study on the effectiveness of silica-rich mineral water on preventing and treating Alzheimer’s Disease;
- Research on the longevity of cell types loaded with aluminum adjuvant and their ability to transport aluminum throughout the body; and
- Studies on ways to identify the susceptibility factors in individuals with autism.
CMSRI-funded Research by Dr. Christopher Exley, et al.
Development of the concept of the body burden of aluminum: what it is, where it comes from and how it impacts upon human health.
The first published, unequivocal evidence that the types of cells that are known to populate a vaccine injection site actually take up aluminum adjuvant into their cell bodies.
Human Exposure to Aluminum in Neurodegenerative Diseases
Evidence that aluminum must now be considered to play a role in Alzheimer’s disease.
The Identification of Aluminum in Human Brain Tissue
First use of lumogallion and fluorescence microscopy to identify aluminum in brain tissue in an individual who died of Alzheimer’s disease following significant environmental exposure to aluminum.
The Cellular Fate and Toxicity of Aluminum Adjuvants used in Human Vaccinations
Development of fluorescence microscopy to compare how cells are affected by different aluminum adjuvants; evidence showed more cell death by the adjuvant AdjuPhos and more likely translocation to other tissues away from injection site with AlHydrogel.
Aluminum in Brain Tissue in Familial Alzheimer’s Disease
Examination of rare brain tissue for 12 cases of early onset Alzheimer’s found highest content of aluminum in human brain tissue yet recorded and unique location of aluminum; study concluded that genetic mutations known to predispose individuals to early onset Alzheimer’s also predispose the same individuals to accumulate/retain aluminum in their brain tissues AND that aluminum is a definite contributor to Alzheimer’s disease.
Particle Size Distributions of Common Aluminum Adjuvants
Determination of aluminum adjuvant particle sizes concluded that AlHydrogel particles are smaller than AdjuPhos and can explain why AlHydrogel is more efficiently taken up by cells at vaccine injection sites.
Aluminum Now Considered a Primary Aetiological Factor in Alzheimer’s Disease
The definitive statement, published in the prestigious Journal of Alzheimer’s Disease, that human exposure to aluminum should now be considered a primary aetiological factor in Alzheimer’s disease.
Aluminum in Brain Tissue in Autism
In addition to identifying extremely high levels of aluminum in brain tissue of individuals who died with autism, this landmark study found the majority of aluminum was intracellular and associated with pro-inflammatory cells both in the brain (microglia). Evidence showed aluminum in lymphocytes (and similar cells) in the rest of the body was being transported from both the lymphatic system and the blood to the brain, suggesting aluminum adjuvants in vaccines may contribute to autism.
Cellular Uptake of Vaccine Adjuvants and Antigens
Discovery that antigens and adjuvants are taken up as separate particles have implications for the formulation of vaccines and how they deliver immunity and the possible role of aluminum adjuvants in instigating serious adverse events distant from the vaccine injection site.
Aluminum in Brain Tissue in Multiple Sclerosis
Abnormally high amounts of aluminum found in MS brain tissue showed the association of aluminum with certain neuropathological features that are characteristic of MS.
Aluminum-based Adjuvants and Adverse Reactions
A review of the properties of aluminum adjuvants, how they work and why they can be responsible for severe adverse events following vaccination.
Research Awaiting Publication:
Aluminum-Tainted Infant Formula -- demonstrating that off-the-shelf infant formulas and those designed for infants with allergies, intolerances, etc. are contaminated with aluminum.
Aluminum and Epilepsy - A study of the brain tissue of an epileptic individual.
Dr. Exley and his team intend to continue seeking the answers to today's chronic illness, autism and Alzheimer's epidemic in order to identify the causes and improve the prognoses. Funding for medical and scientific research is most typically provided by industries that hope to profit from the results (e.g., pharmaceutical companies), therefore, it is up to private individuals, nonprofits and foundations to support independent research.
